Skip to main content
OpenTrials
Completed

NCT Number: NCT03506503

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Androgenic Alopecia Alopecia Central Nervous System Diseases Central Nervous System Infections Dyssomnias Hair Diseases Hypotrichosis Infections Insomnia, Fatal Familial Nervous System Diseases Neurodegenerative Diseases Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Prion Diseases Skin Diseases Skin and Connective Tissue Diseases Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

18 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

the first affiliated hospital of Jinan University

Guangzhou, Guangdong, 510000, China

About this study

The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up.

Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male patients with androgenic alopecia aging from 18 to 50.
  • No scars and wounds on the alopecia area.
  • No skin disease or serious cardiovascular disease.
  • Preoperative examinations remain healthy.

Exclusion criteria

  • Serious chronic heart, liver, kidney, blood system disease
  • Allergic diseases, skin inflammation or wounds
  • Alopecia but not androgenic alopecia
  • Acute or chronic infection
  • Take anticoagulant drugs
  • Active vitiligo, psoriasis, systemic lupus erythematosus

Treatment and study plan

Nanofat grafting

Procedure

hair loss area will be treated by processed autologous Nanofat grafting

Primary outcomes

  1. Dermatoscope

    Time frame: Baseline and at1,3,6,9,12 months after the treatment

    the density of hair follicle and diameter of hair will be analized by dermatoscope before and after the treatment of Nanofat grafting.

Other outcomes

  1. Satisfaction assessments

    Time frame: 1,3,6,12 months after treatment

    the satisfaction will be assessed after the treatment

Sponsors and collaborators

Lead sponsor

Jinan University Guangzhou

Other

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Apr 24, 2018
Registry last updated
Feb 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.